Board approves variation in use of IPO proceeds, seeks shareholder approval

Results View source PDF Explain this filing

SENORES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹1326.90

prior close

₹1329.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-0.5% vs market

Pharmaceuticals peers, median of 165sector+0.8%-0.3% vs sector

On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-0.2

15m

+0.4

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+1.0-0.5+0.8-0.3

Next day

-1.3+1.2-2.5+0.3-1.6

+0.6+2.1-1.4+0.9-0.2

+4.7+1.7+2.9+1.2+3.5

+1.9+1.9-0.0+0.6+1.3

+2.8+1.2+1.5+0.1+2.6

+6.9+1.1+5.8+0.6+6.3

15d

+6.0+1.6+4.3+1.7+4.2

-2.7+0.1-2.8-0.3-2.5

+8.9+6.6+2.2+2.7+6.2

+4.5+5.5-0.9+3.2+1.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Senores Pharmaceuticals board, on June 29, 2026, approved a proposed change in the use of about Rs 1,000.16 million of unutilised IPO proceeds, out of total primary IPO proceeds of Rs 5,000 million. The change requires shareholder approval via postal ballot. The board meeting ran from 4:15 PM to 5:00 PM IST.

Likely market impact

Shareholders will vote on reallocating about 20% of IPO funds; outcome could affect growth plans and investor sentiment.